Herbert Lepor, MD

Herbert Lepor, MD

NYU Langone Health

New York, New York

Dr. Herbert Lepor serves as a Professor of Urology, Biochemistry, and Molecular Pharmacology and as the Martin Spatz Chairman of the Department of Urology at NYU Langone Health in New York City. His clinical practice is devoted exclusively to the surgical management of prostate cancer. He also serves as Chairman of the Scientific Advisory Board at UroGen Pharmaceuticals, Ltd., and has served as a member of the Medical Advisory Board at Skyline Medical, Inc. He has served on the editorial boards of several major urological journals and has authored several hundred peer-reviewed articles, along with numerous book chapters and books.

Disclosures:

Articles by Herbert Lepor, MD

Is Focal Ablation of Prostate Cancer Ready for Prime Time?

Is Focal Ablation of Prostate Cancer Ready for Prime Time?

Posted by | May 2018

Herbert Lepor, MD, defines focal ablation and its quality of life, oncological, and cost benefits to patients. He then discusses best practices for the procedure, including optimal patient selection, energy source options, and extent of the ablation zone. Furthermore, he explains the research and improvement needed to make focal ablation of prostate cancer ready for prime time.

Read More

Join the GRU Community

- Why Join? -

CARDEN JENNINGS PUBLISHING CO., LTD.

Find Us:
375 Greenbrier Drive, Suite 100
Charlottesville, VA 22901

Call Us:
434-817-2000

Email Us:
Send Message

INFO

Privacy Policy
Terms & Conditions

Your GRU

– Account Dashboard
– Your Courses

Exercise & Wellness

Associate Editors


Fred Bartlit, Esq.
StrongPath


Mark A. Moyad, MD, MPH
University of Michigan
Ann Arbor, Michigan